Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Environmental Pollution (Barking, Essex : 1987)|August 2, 2019
Characteristic and human exposure risk assessment of per- and polyfluoroalkyl substances: A study based on indoor dust and drinking water in ChinaJunjie Ao, Tao Yuan, Hui Xia, et al.
The Science of the Total Environment|July 10, 2024
Environmental exposure patterns to 94 current-use pesticides in women of reproductive age who are preparing for pregnancyTian Tian, Fang Liu, Yu Fu, et al.
Environment International|March 31, 2020
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort studyXiaona Huo, Rong Huang, Yuexin Gan, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
Cellular Signalling|November 28, 2025
Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinomaNa Qiang, Cheng Lan, An Lin, et al.
International Journal of Molecular Sciences|July 27, 2022
The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma CellsHiroaki Kanzaki, Tetsuhiro Chiba, Tatsuya Kaneko, et al.
American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
BMC Cancer|November 14, 2019
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinomaTakahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, et al.
Oncology Letters|August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancerYushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Biochemical Pharmacology|February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
Pageof 5